Clifford Swan Investment Counsel’s Idexx Laboratories IDXX Stock Holding History

Clifford Swan Investment Counsel’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-314	Closed	-$207K	–	327
2021 Q4	$207K	Hold	314	–	–	0.01%	328
2021 Q3	$209K	Hold	314	–	–	0.01%	320
2021 Q2	$219K	Buy	+314	New	+$173K	0.01%	312
2021 Q1	–	Sell	-454	Closed	-$227K	–	324
2020 Q4	$227K	Buy	+454	New	+$203K	0.01%	299

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Clifford Swan Investment Counsel's IDXX Position: Q1 2022 in Review

Clifford Swan Investment Counsel sold out of Idexx Laboratories (IDXX) in Q1 2022, closing a stake of 314 shares — an estimated $207K sold.

Clifford Swan Investment Counsel first reported a position in IDXX in Q4 2020 and held it in 4 quarters. The position peaked at $227K in Q4 2020. 1,033 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.

Clifford Swan Investment Counsel reported no remaining Idexx Laboratories position as of Q1 2022 after selling out during the quarter.
Clifford Swan Investment Counsel sold 314 Idexx Laboratories shares in Q1 2022, an estimated $207K.
Clifford Swan Investment Counsel first reported a position in Idexx Laboratories in Q4 2020 and held it in 4 quarters.
Clifford Swan Investment Counsel's Idexx Laboratories position peaked at $227K in Q4 2020.
1,033 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.

Based on Clifford Swan Investment Counsel's 13F filing for Q1 2022, filed 3 May 2022.